Kyntra Bio(CH:KYNB)
CH:KYNB
Kyntra Bio earnings date
Kyntra Bio (KYNB) Q3 2021 Earnings Report
0 Followers
CH:KYNB Q3 2021 EPS Results
- Actual EPS
- CHF 11.34
- Consensus EPS
- -CHF 0.15
- Beat/Miss
- Beat by +CHF 11.49
- One Year Ago EPS
- CHF 7.35
CH:KYNB Q3 2021 Revenue Results
- Actual Revenue
- CHF 131.07M
- Expected Revenue
- CHF 109.03M
- Beat/Miss
- Beat by +CHF 22.05M
- YoY Revenue Growth
- +254.23%
Earnings Announcement Details
- Quarter
- Q3 2021
- Date
- 11/09/2021
- Time
- After Close
- Conference Call
- Tuesday, November 9, 2021
CH:KYNB Upcoming Earnings
Kyntra Bio's next earnings date is estimated for March 1, 2027, based on past reporting schedules.
Q3 2021 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q3 2021 Earnings Slide Deck
No slide deck is available for this earnings event.
Q3 2021 Earnings Call Summary
No earnings call summary is available for this earnings event.
CH:KYNB Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 01, 2027 | 2026 (Q4) | -1.86- | -2.95 | ― | ― |
| Nov 16, 2026 | 2026 (Q3) | ―0.03 | 41.69 | -99.92% (-41.66) | |
| Aug 13, 2026 | 2026 (Q2) | -2.682.49 | -1.58 | 257.45% (+4.07) | |
| May 11, 2026 | 2026 (Q1) | -2.82-3.16 | 1.05 | -400.80% (-4.21) | |
| Mar 16, 2026 | 2025 (Q4) | -3.26-2.95 | 3.78 | -178.00% (-6.73) | |
| Nov 10, 2025 | 2025 (Q3) | -3.3741.69 | -3.57 | 1267.29% (+45.26) | |
| Aug 11, 2025 | 2025 (Q2) | -1.94-1.58 | -3.36 | 53.00% (+1.78) | |
| May 12, 2025 | 2025 (Q1) | 0.631.05 | -6.93 | 115.15% (+7.98) | |
| Mar 17, 2025 | 2024 (Q4) | -2.943.78 | -11.98 | 131.58% (+15.76) | |
| Nov 12, 2024 | 2024 (Q3) | -6.44-3.57 | -13.66 | 73.85% (+10.08) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed

